11 Results for "

Vorinostat

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Vorinostat" in MCE Product Catalog:

171
171 Cited Publications
Cat. No.: HY-10221
CAS No.: 149647-78-9
Purity:  99.58%
Synonyms: SAHA; Suberoylanilide hydroxamic acid
Research Areas:  

Infection Cancer

Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis . Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification .
loading...
    loading...
Cat. No.: HY-10221R
CAS No.: 149647-78-9
Synonyms: SAHA (Standard); Suberoylanilide hydroxamic acid (Standard)
Vorinostat (Standard) is the analytical standard of Vorinostat. This product is intended for research and analytical applications. Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis . Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification .
loading...
    loading...
Cat. No.: HY-155248
CAS No.: 1448355-15-4
Purity:  98.40%
Target:  

HDAC

Research Areas:  

Cancer

HL23 is a histone deacetylase (HDAC) inhibitor with activity against hepatocellular carcinoma (HCC). HL23 enhances acetylation of the TXNIP promoter and upregulates TXNIP expression, thereby mediating potassium channel activity and triggering TXNIP-dependent potassium deprivation. HL23 inhibits HCC progression and metastasis and has a synergistic effect with Sorafenib (HY-10201) and is more potent than Sorafenib+Vorinostat (HY-10221) .
loading...
    loading...
Cat. No.: HY-111595
CAS No.: 1613617-05-2
Purity:  97.00%
Research Areas:  

Cancer

SAHA chloroalkane T1 is a chloroalkane capture tag by tethering Vorinostat (SAHA) and a chloroalkane tag T1 .
loading...
    loading...
Cat. No.: HY-115412
CAS No.: 1132749-48-4
Purity:  ≥99.0%
Synonyms: SAHA-d5; Suberoylanilide hydroxamic acid-d5
Research Areas:  

Infection Cancer

Vorinostat-d5 (SAHA-d5) is the deuterium labeled Vorinostat. Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis . Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification .
loading...
    loading...
Cat. No.: HY-Z12208
CAS No.: 1305124-48-4
N1-Phenylsuberamide is an organic amide compound, and its structure can be regarded as a simplified analogue of Vorinostat (HY-10221). N1-Phenylsuberamide exhibits moderate anti-proliferative activity against MDA-MB-231 and MCF-7 cells. N1-Phenylsuberamide does not show significant HDAC inhibitory activity and can only weakly induce the expression of the p21 gene. N1-Phenylsuberamide has extremely low relative binding affinity of estrogen receptor. N1-Phenylsuberamide can be used as a control compound .
loading...
    loading...
Cat. No.: HY-10221G
CAS No.: 149647-78-9
Synonyms: SAHA (GMP); Suberoylanilide hydroxamic acid (GMP)
Vorinostat (GMP) is a GMP grade Vorinosta (HY-10221). GMP-grade small molecules can be used as auxiliary agents in cell therapy. Vorinostat is a potent, orally available HDAC1, HDAC2, HDAC3 (Class I), HDAC6 and Inhibitors of HDAC7 (Class II) and Class IV (HDAC11) .
loading...
    loading...
Cat. No.: HY-168864
Research Areas:  

Cancer

HDAC ligand-5 is a template for the non-selective HDAC inhibitor Vorinostat (HY-10221). HDAC ligand-5 can serve as a ligand for target protein (Ligands for Target Protein for PROTAC) for the development of PROTAC HDAC degraders with antitumor activity. HDAC ligand-5 can be used for the synthesis of FF2049 (HY-168863) .
loading...
    loading...
Cat. No.: HY-175857
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC-IN-92 is a pan-HDAC inhibitor with an IC50 of 12.58 µM in A2780 cells. HDAC-IN-92 demonstrates broad-spectrum, notable cytotoxic activity against a range of human cancer cell lines, including ovarian, liver, and breast carcinomas. HDAC-IN-92 causes apoptosis and demonstrates a notable decrease in tumor cell colony formation. HDAC-IN-92 inhibits the formation of blood vessels in the chick chorioallantoic membrane (CAM). HDAC-IN-92 exhibits anti-tumor effect in a 4T1 tumor-bearing mouse model. HDAC-IN-92 can be used for research targeting solid tumor .
loading...
    loading...
Cat. No.: HY-111595R
CAS No.: 1613617-05-2
Research Areas:  

Cancer

SAHA chloroalkane T1 (Standard) is the analytical standard of SAHA chloroalkane T1 (HY-111595). This product is intended for research and analytical applications. SAHA chloroalkane T1 is a chloroalkane capture tag by tethering Vorinostat (SAHA) and a chloroalkane tag T1 .
loading...
    loading...
Cat. No.: HY-W014552
CAS No.: 6269-89-2
Target:  

Drug Intermediate

Research Areas:  

Cancer

1-(4-Nitrophenyl)piperazine (Compound 15) is a piperazine linker that can be used for the synthesis of HDAC3/6-IN-2 (HY-133147). HDAC3/6-IN-2 is an anti-cancer compound formed by connecting CDODA-Me and Vorinostat (HY-10221) through the piperazine linker .
loading...
    loading...
  • 1